GNNSF (Genscript Biotech) Long-Term Debt : $17.3 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Genscript Biotech Long-Term Debt?

Genscript Biotech's Long-Term Debt for the quarter that ended in Dec. 2024 was $17.3 Mil.

Genscript Biotech's quarterly Long-Term Debt increased from Dec. 2023 ($287.2 Mil) to Jun. 2024 ($305.0 Mil) but then declined from Jun. 2024 ($305.0 Mil) to Dec. 2024 ($17.3 Mil).

Genscript Biotech's annual Long-Term Debt increased from Dec. 2022 ($261.0 Mil) to Dec. 2023 ($287.2 Mil) but then declined from Dec. 2023 ($287.2 Mil) to Dec. 2024 ($17.3 Mil).

Genscript Biotech Long-Term Debt Historical Data

The historical data trend for Genscript Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Long-Term Debt Chart

Genscript Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

1.26

121.07

261.01

287.21

17.31

Genscript Biotech Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															261.01	270.61	287.21	305.05	17.31

Genscript Biotech (OTCPK:GNNSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Genscript Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (OTCPK:GNNSF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

01548:Hong Kong G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend.